Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Immunity Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Antigens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2017

A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice

Foote, J. B., Kok, M., Leatherman, J. M., Armstrong, T. D., Marcinkowski, B. C., Ojalvo, L. S., Kanne, D. B., Jaffee, E. M., Dubensky, T. W. & Emens, L. A. Jun 1 2017 In : Cancer Immunology Research. 5, 6, p. 468-479 12 p.

Research output: Contribution to journalArticle

OX40 Receptor
Interferons
Immunity
T-Lymphocytes
Genes

Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo

Sunay, M. M. E., Foote, J. B., Leatherman, J. M., Edwards, J. P., Armstrong, T. D., Nirschl, C. J., Hicks, J. & Emens, L. A. May 1 2017 In : International Immunopharmacology. 46, p. 112-123 12 p.

Research output: Contribution to journalArticle

Immunity
Vaccination
T-Lymphocytes
Neoplasms
Tumor Microenvironment

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

De Remigis, A., De Gruijl, T. D., Uram, J. N., Tzou, S. C., Iwama, S., Talor, M. V., Armstrong, T. D., Santegoets, S. J. A. M., Slovin, S. F., Zheng, L., Laheru, D. A., Jaffee, E. M., Gerritsen, W. R., Van Den Eertwegh, A. J. M., Le, D. T. & Caturegli, P. Jan 1 2015 In : International Journal of Cancer. 136, 1, p. 127-137 11 p.

Research output: Contribution to journalArticle

Thyroglobulin
Immunotherapy
Antibodies
Neoplasms
Epitopes

Galectin-3 shapes antitumor immune responses by suppressing CD8 T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells

Kouo, T., Huang, L., Pucsek, A. B., Cao, M., Solt, S., Armstrong, T. & Jaffee, E. Apr 1 2015 In : Cancer immunology research. 3, 4, p. 412-423 12 p.

Research output: Contribution to journalArticle

Galectin 3
Dendritic Cells
T-Lymphocytes
T-Cell Antigen Receptor
Adenocarcinoma
Vaccines
Antigens
Neoplasms
Early Detection of Cancer
Carcinogenesis